John T Wilson Selected Research

John T Wilson Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 04/2014
14	Bites and Stings (Sting) 04/2024 - 01/2019
5	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2016
5	Melanoma (Melanoma, Malignant) 10/2023 - 11/2018
4	Infections 08/2023 - 10/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2014
3	Hemolysis 12/2022 - 03/2015
3	Communicable Diseases (Infectious Diseases) 11/2022 - 04/2021
3	Inflammation (Inflammations) 04/2019 - 09/2008
2	Triple Negative Breast Neoplasms 04/2024 - 08/2016
2	Carcinoma (Carcinomatosis) 02/2024 - 01/2023
2	Human Influenza (Influenza) 04/2021 - 10/2019
2	Thrombosis (Thrombus) 06/2010 - 09/2008
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2010 - 09/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2024
1	Colitis 04/2024
1	Macular Degeneration (Age-Related Maculopathy) 04/2024
1	Non-alcoholic Fatty Liver Disease 04/2024
1	Relapsing-Remitting Multiple Sclerosis 01/2023
1	Plague (Bubonic Plague) 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Experimental Melanoma 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Anterior Cruciate Ligament Injuries 05/2021
1	Tuberculosis (Tuberculoses) 04/2021
1	Wounds and Injuries (Trauma) 11/2020
1	Infectious Ectromelia 01/2020
1	Vaccinia 10/2019
1	Rupture 04/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Intractable Pain 10/2018
1	Stress Fractures (Stress Fracture) 10/2018

Drug/Important Bio-Agent (IBA)

12	InterferonsIBA 04/2024 - 01/2019
10	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
9	LigandsIBA 04/2024 - 01/2018
7	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024 - 01/2019
6	PolymersIBA 03/2024 - 03/2015
6	CytokinesIBA 01/2023 - 11/2018
6	VaccinesIBA 01/2022 - 11/2018
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2024 - 11/2018
5	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2018
5	AntigensIBA 02/2024 - 01/2020
4	Nucleic AcidsIBA 01/2023 - 10/2019
3	Vaccine AdjuvantsIBA 04/2024 - 01/2018
3	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2018
3	Peptides (Polypeptides)IBA 02/2024 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2019
3	Cancer VaccinesIBA 01/2022 - 11/2018
2	NanovaccinesIBA 02/2024 - 01/2020
2	GoldIBA 01/2020 - 08/2016
2	Therapeutic UsesIBA 11/2018 - 08/2016
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	OligonucleotidesIBA 04/2024
1	RU.521IBA 04/2024
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2024
1	MethacrylatesIBA 03/2024
1	EnzymesIBA 03/2024
1	ProdrugsIBA 03/2024
1	Alkynes (Acetylenes)IBA 03/2024
1	Cathepsin BIBA 03/2024
1	AzidesIBA 03/2024
1	immune RNA (I-RNA)IBA 01/2023
1	Inosine FDA Link 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	nile redIBA 12/2022
1	Subunit VaccinesIBA 11/2022
1	AntibodiesIBA 10/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	Biocompatible Materials (Biomaterials)IBA 04/2021
1	PolyelectrolytesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Deoxyribonucleases (DNase)FDA Link 01/2021
1	AllodermIBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	HLA-B*07 antigenIBA 01/2020
1	LuciferasesIBA 10/2019
1	CathepsinsIBA 04/2019
1	Protons (Proton)IBA 04/2019
1	CaspasesIBA 04/2019
1	Small Interfering RNA (siRNA)IBA 04/2019
1	InflammasomesIBA 04/2019
1	triphosphoric acid (triphosphate)IBA 01/2019
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2019
1	Interferon Type IIBA 01/2019
1	NucleotidesIBA 11/2018
1	ChemokinesIBA 11/2018
1	Galactosylceramides (Galactocerebrosides)IBA 11/2018
1	Bone Cements (Bone Glue)IBA 10/2018
1	Calcium Sulfate (Alabaster)IBA 10/2018
1	Polymethyl Methacrylate (Sol)IBA 10/2018

Therapy/Procedure

17	Immunotherapy 04/2024 - 11/2018
10	Therapeutics 04/2024 - 09/2008
2	Intravenous Administration 12/2023 - 10/2021
2	Islets of Langerhans Transplantation 06/2010 - 09/2008
1	Drug Therapy (Chemotherapy) 04/2024
1	Hemiarthroplasty 08/2023
1	Hip Replacement Arthroplasty (Total Hip Replacement) 05/2021
1	Orthopedic Procedures 10/2018
1	Injections 10/2018